What is interventional oncology ablation?

Interventional oncology ablation refers to a minimally invasive medical procedure used to treat cancerous tumors. It involves the use of various energy sources, such as radiofrequency, microwave, or cryoablation, to destroy or remove cancer cells while preserving surrounding healthy tissue.

How big is the Interventional Oncology Ablation Market?

The global Interventional Oncology Ablation Market size was estimated at USD 550.0 Million in 2023 and is expected to reach USD 1290.2 Million in 2033.

What is the Interventional Oncology Ablation Market growth?

The global Interventional Oncology Ablation Market is expected to grow at a compound annual growth rate of 8.9%. From 2024 To 2033

Who are the key companies/players in the Interventional Oncology Ablation Market?

Some of the key players in the Interventional Oncology Ablation Markets are Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems, STARmed Co., Biomedical, Terumo Corporation.

What types of cancer can be treated with interventional oncology ablation?

Interventional oncology ablation is used to treat solid tumors in various organs, including the liver, kidney, lung, and bone. It can also be applied to manage metastatic lesions.

How does interventional oncology ablation work?

The procedure typically involves the insertion of a specialized needle or catheter into the tumor under guidance from imaging techniques like ultrasound, CT, or MRI. Energy is then delivered through the needle or catheter to heat or freeze the tumor, effectively destroying cancer cells.

What are the advantages of interventional oncology ablation?

The advantages include minimal invasiveness, shorter recovery times, reduced pain, and preservation of healthy tissue. It is often suitable for patients who are not candidates for surgery.

Are there any risks or side effects associated with interventional oncology ablation?

Like any medical procedure, there are risks, which can include infection, bleeding, or damage to nearby organs. However, these risks are generally low, and complications are rare.

Global Interventional Oncology Ablation Market By Product Type (Ablation Devices, Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Others) By Procedure (Radioembolization, Ablation Procedures, Thermal, Non-Thermal, TACE, TARE, Others) By Indication (Liver Cancer, Kidney Cancer, Lung Cancer, Others) By End-Use (Hospitals, Ambulatory Surgical Centers, Others) and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Jan 2024
Report ID: 84491
Number of Pages: 385
Format:

- Boston Scientific Corporation Company Profile
- Johnson & Johnson
- Medtronic Plc
- Varian Medical Systems
- EDAP TMS S.A.
- AngioDynamics
- CASCINATION AG
- Merit Medical Systems
- STARmed Co.
- Biomedical
- Terumo Corporation Company Profile

Related Reports

Our Clients

Report ID 84491
Published Date Jan 2024
Rating
- ★★★★★
  
  ★★★★★
- (91)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible